Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.50 (2.50%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £14.99m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Director/PDMR Dealing

9 Apr 2026 12:00

RNS Number : 8569Z
Altitude Group PLC
09 April 2026
 

9 April 2026

 

 

Altitude Group plc

("Altitude" or the "Company")

 

Director/PDMR Dealing

 

Altitude Group plc (AIM: ALT), a technology and services provider specialising in end-to-end solutions for the branded merchandise and promotional products industry, announces the following dealings made by a director in its ordinary shares of 0.4p each ("Ordinary Shares").

 

Bob Wigley, Non-Executive Director, purchased 200,000 Ordinary Shares at an average price of 22.325 pence per share. Following the purchase of Ordinary Shares, Bob Wigley's beneficial holding is 200,000 Ordinary Shares, representing approximately 0.27% of the Company's issued share capital.

 

For further information, please contact:

 

Altitude Group plc

Alexander Brennan, Executive Chair

Drew Whibley, Chief Financial Officer

Deborah Wilkinson, Chief Operating Officer

Via Singer Capital Markets

 

 

Singer Capital Markets

Tel: +44 (0) 20 7496 3000

James Moat / James Fischer / Carl Diebitsch

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Bob Wigley

2.

Reason for the notification

a.

Position/status

Non-Executive Director

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Altitude Group plc

b.

LEI

213800VACSTYYSI39R89

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.4p each

 

GB00B0LSFV82

b.

Nature of the transaction

Purchase of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

21.25p

23.40p

100,000

100,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

200,000 Ordinary Shares

 

22.325p per Ordinary Share

e.

Date of the transaction

2 April 2026

8 April 2026

f.

Place of the transaction

London Stock Exchange, AIMX

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHILMMTMTAMBFF
Date   Source Headline
5th Jan 20246:06 pmRNSDirector/PDMR Dealing
12th Dec 20236:04 pmRNSDirector/PDMR Dealing
11th Dec 20237:00 amRNSHistoric Related Party Transactions
30th Nov 20237:00 amRNSHoldings in Company and Director Dealing
28th Nov 20237:00 amRNSInterim Results
24th Nov 20237:00 amRNSInvestor Presentation
27th Oct 20237:00 amRNSTrading Update and Director Share Awards
15th Sep 20237:00 amRNSResult of AGM
18th Aug 20237:00 amRNSPosting of Annual Report and Accounts
26th Jul 202312:00 pmRNSInvestor Presentation via Investor Meet Company
25th Jul 20237:00 amRNSAudited Final Results and Notice of AGM
20th Jul 20237:00 amRNSNotice of Results
8th Jun 20237:00 amRNSPre-Close Trading Update
11th Apr 20234:43 pmRNSDirector Dealing
29th Mar 20237:05 amRNSDirector Dealing
29th Mar 20237:00 amRNSHoldings in Company and Director Dealing
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20232:05 pmRNSSecond Price Monitoring Extn
28th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 202311:05 amRNSSecond Price Monitoring Extn
28th Mar 202311:00 amRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSMajor Contract Wins and Trading Update
16th Feb 20237:00 amRNSHolding(s) in Company
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
14th Feb 20237:00 amRNSTrading Update
17th Jan 20237:00 amRNSAltitude Group PLC at Industry’s Largest Shows
9th Dec 20227:00 amRNSAltitude Group to Present at MelloMonday
29th Nov 20221:59 pmRNSInvestor Presentation
29th Nov 20227:00 amRNSInterim Results
22nd Nov 20227:00 amRNSTrading Update
31st Oct 20227:00 amRNSDirector/PDMR Dealing
28th Oct 20227:00 amRNSGrant of Options
25th Oct 20227:00 amRNSTrading Update
15th Sep 202212:54 pmRNSResult of AGM
6th Sep 20222:40 pmRNSOnline Access to AGM
5th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSAudited Final Results and Notice of AGM
17th Jun 20227:00 amRNSDirector Dealings, Exercise & Grant of Options
31st Mar 20227:00 amRNSTrading Update & Secured Credit Facility
11th Feb 20227:00 amRNSDirector/PDMR Dealing
10th Feb 20227:00 amRNSDirector/PDMR Dealing
1st Dec 20217:00 amRNSDirector/PDMR Dealings
30th Nov 20217:00 amRNSInterim Results
25th Nov 20217:00 amRNSHolding(s) in Company
24th Nov 20217:00 amRNSBoard Changes and Trading Update
5th Oct 20217:00 amRNSAppointment of CFO & Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.